Last updated: October 13, 2023
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
4
Condition
Oral Facial Pain
Headaches
Pain (Pediatric)
Treatment
zolmitriptanee
Valproate
topiramate
Clinical Study ID
NCT06089356
Migraine
Ages 8-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: children with migraine -
Exclusion
Exclusion Criteria: those who suffer from ischemic heart disease , or who have allergy to any of drugs used
Study Design
Total Participants: 90
Treatment Group(s): 3
Primary Treatment: zolmitriptanee
Phase: 4
Study Start date:
January 01, 2023
Estimated Completion Date:
January 01, 2024
Study Description
Connect with a study center
Kafrelsheikh University
Tanta, Kafrelsheikh
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.